| Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma B Heinze, CT Fuss, P Mulatero, F Beuschlein, M Reincke, M Mustafa, ... Hypertension 71 (2), 317-325, 2018 | 86 | 2018 |
| The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy G Eisenhofer, M Kurlbaum, M Peitzsch, G Constantinescu, H Remde, ... The Journal of Clinical Endocrinology & Metabolism 107 (5), e2027-e2036, 2022 | 41 | 2022 |
| Radiation exposure of adrenal vein sampling: a German Multicenter Study CT Fuss, M Treitl, N Rayes, P Podrabsky, WK Fenske, DA Heinrich, ... European Journal of Endocrinology 179 (4), 261-267, 2018 | 34 | 2018 |
| Adrenal venous sampling–guided adrenalectomy rates in primary aldosteronism: results of an international cohort (AVSTAT) Y Ohno, M Naruse, F Beuschlein, F Schreiner, M Parasiliti-Caprino, ... The Journal of Clinical Endocrinology & Metabolism 106 (3), e1400-e1407, 2021 | 33 | 2021 |
| Real-world efficacy and safety of multi-tyrosine kinase inhibitors in radioiodine refractory thyroid cancer VF Koehler, E Berg, P Adam, GL Weber, A Pfestroff, M Luster, JM Kutsch, ... Thyroid 31 (10), 1531-1541, 2021 | 19 | 2021 |
| Impact of the chemokine receptors CXCR4 and CXCR7 on clinical outcome in adrenocortical carcinoma I Chifu, B Heinze, CT Fuss, K Lang, M Kroiss, S Kircher, CL Ronchi, ... Frontiers in Endocrinology 11, 597878, 2020 | 18 | 2020 |
| Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism C Adolf, LT Braun, CT Fuss, S Hahner, H Künzel, L Handgriff, L Sturm, ... Endocrine 69, 625-633, 2020 | 14 | 2020 |
| The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex–a multicenter-study of 3566 Caucasian and Asian subjects A Spyroglou, L Handgriff, L Müller, P Schwarzlmüller, M Parasiliti-Caprino, ... European Journal of Endocrinology 187 (3), 361-372, 2022 | 12 | 2022 |
| Improved diagnostic accuracy of clonidine suppression testing using an age-related cutoff for plasma normetanephrine H Remde, C Pamporaki, M Quinkler, S Nölting, A Prejbisz, HJLM Timmers, ... Hypertension 79 (6), 1257-1264, 2022 | 12 | 2022 |
| Case report: abdominal lymph node metastases of parathyroid carcinoma: diagnostic workup, molecular diagnosis, and clinical management C Lenschow, CT Fuss, S Kircher, A Buck, R Kickuth, J Reibetanz, ... Frontiers in endocrinology 12, 643328, 2021 | 12 | 2021 |
| Prevalence of malignancies in patients with primary aldosteronism K Lang, K Weber, M Quinkler, AS Dietz, H Wallaschofski, A Hannemann, ... The Journal of Clinical Endocrinology & Metabolism 101 (4), 1656-1663, 2016 | 12 | 2016 |
| Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS CT Fuss, K Brohm, M Kurlbaum, A Hannemann, S Kendl, M Fassnacht, ... European Journal of Endocrinology 184 (1), 167-178, 2021 | 11 | 2021 |
| Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series VF Koehler, CT Fuss, CM Berr, K Frank‐Raue, F Raue, E Hoster, ... Clinical Endocrinology 96 (6), 847-856, 2022 | 9 | 2022 |
| Reduction of radiation exposure in adrenal vein sampling: impact of the rapid cortisol assay AM Augustin, G Dalla Torre, CT Fuss, M Fassnacht, TA Bley, R Kickuth RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden …, 2021 | 9 | 2021 |
| Continuous rhPTH (1–34) treatment in chronic hypoparathyroidism CT Fuss, S Burger-Stritt, S Horn, AC Koschker, K Frey, A Meyer, S Hahner Endocrinology, diabetes & metabolism case reports 2020 (1), 2020 | 8 | 2020 |
| Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled … E Baudin, B Goichot, A Berruti, J Hadoux, S Moalla, S Laboureau, ... The Lancet, 2024 | 6 | 2024 |
| USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K C Prieto‐Garcia, O Hartmann, M Reissland, F Braun, S Bozkurt, N Pahor, ... Molecular Oncology 16 (17), 3082-3106, 2022 | 6 | 2022 |
| Targeting 11-Beta Hydroxylase With [131I]IMAZA: A Novel Approach for the Treatment of Advanced Adrenocortical Carcinoma S Hahner, PE Hartrampf, PW Mihatsch, M Nauerz, B Heinze, H Hänscheid, ... The Journal of Clinical Endocrinology & Metabolism 107 (4), e1348-e1355, 2022 | 6 | 2022 |
| Treatment of RET-positive advanced medullary thyroid cancer with multi-tyrosine kinase inhibitors—a retrospective multi-center registry analysis VF Koehler, P Adam, CT Fuss, L Jiang, E Berg, K Frank-Raue, F Raue, ... Cancers 14 (14), 3405, 2022 | 4 | 2022 |
| Reassessment of postural stimulation testing as a simple tool to identify a subgroup of patients with unilateral primary aldosteronism C Teresa Fuss, K Brohm, M Fassnacht, M Kroiss, S Hahner The Journal of Clinical Endocrinology & Metabolism 107 (2), e865-e873, 2022 | 4 | 2022 |
